No Detail Found!

A case of carbamazepine-induced toxic epidermal necrolysis in an Afghan woman

Author(s)
Muhammad Ijaz Departments of Medicine, Northwest General Hospital and Research Center, Hayatabad, Peshawar, Pakistan
Iftikhar Ali Pharmacy Services, Northwest General Hospital and Research Center, Hayatabad, Peshawar, Pakistan; Department of Pharmacy, University of Swabi, Khyber Pakhtunkhwa, Pakistan
Khatira Wahid Departments of Medicine, Northwest General Hospital and Research Center, Hayatabad, Peshawar, Pakistan
Aziz Ullah Khan Pharmacy Services, Northwest General Hospital and Research Center, Hayatabad, Peshawar, Pakistan; Department of Pharmacy, University of Swabi, Khyber Pakhtunkhwa, Pakistan
Abstract
We present a case of a 55y-ear-old diabetic woman who presented to the clinic with an erythematous, scaly, itchy rash and generalized abdominal pain with vomiting. Owing to the symptoms of peripheral neuropathy, she had been prescribed carbamazepine 100 mg twice daily. Initially, the patient presented with the rash on her face along with sticky eyelashes, which later spread to chest, abdomen, and thighs. Blood cultures and wound swabs were taken, carbamazepine was stopped, a working diagnosis of toxic epidermal necrolysis (TEN) with prerenal acute kidney injury was made. Her renal functions were deranged with a serum urea of 170 mg/dL, serum creatinine 3.3 mg/dL, lactic acid 43 mg and estimated glomerular filtration rate (eGFR)15.3 ml/min/1.73 m2. There was no biochemical improvement observed, postdialysis. She developed left leg arterial ischemia with numbness, bluish discoloration of the skin, and hypotension. Ultimately, the patient went into multi-organ failure and unfortunately passed away. Serious and, sometimes, fatal dermatological reactions have been reported during the treatment with carbamazepine. Although carbamazepinei-nduced TEN is not a rare presentation, other similar drugs with a safer side effect profile could be used instead as in the case of our patient.
Publication Details
Page(s) 177-181
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
toxic epidermal necrolysis, Anticonvulsants, drug reactions
References
Patel TK,Thakkar SH,Sharma D. .2014 .Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J, 5(Suppl 2) : S76-86.
Habib A,Pasha W,Raza N. .2010 .Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child. J Coll Physicians Surg Pak, 20 : 2057.
Fritsch PO,Sidoroff A .2000 .Drug‑induced Stevens‑Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol, 1 : 349-60.
Gardezi SA,Kazmi AH,Aman S,Nadeem M,Khan MS,Sohail M. .2013 .A clinicoetiological study of Stevens‑Johnson syndrome and toxic epidermal necrolysis. J Park Assoc Dermatol, 23 : 5-13.
Epidermal Toxic . .Necrolysis [Database on the Internet]. html. [Last accessed on 2016 Apr, 21 : .
Kim EJ,Lim H,Park SY,Kim S,Yoon SY,Bae YJ .2014 .Rapid onset of StevensJ‑ohnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pac Allergy, 4 : 68-72.
Roujeau JC,Kelly JP,Naldi L,Rzany B,Stern RS,Anderson T .1995 .Medication use and the risk of Stevens‑Johnson syndrome or toxic epidermal necrolysis. N Engl J Med, 333 : 1600-7.
Pereira FA,Mudgil AV,Rosmarin DM .2007 .Toxic epidermal necrolysis. J Am Acad Dermatol, 56 : 181-200.
JC Roujeau .1993 .Drug‑induced toxic epidermal necrolysis. II. Current aspects. Clin Dermatol, 11 : 493-500.
Yalcin AD,Karakas AA,Soykam G,Gorczynski RM,Sezer C,Bisgin A .2013 .A case of toxic epidermal necrolysis with diverse etiologies: Successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels. Clin Lab, 59 : 6815.
Aires DJ,Fraga G,Korentager R,Richie CP,Aggarwal S,Wick J .2013 .Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality. J Drugs Dermatol, 12 : 679-84.
Lee HY,Chung WH .2013 .Toxic epidermal necrolysis: The year in review. Curr Opin Allergy Clin Immunol, 13 : 3306.
McGee T,Munster A .1998 .Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg, 102 : 1018-22.
Revuz J,Penso D,Roujeau JC,Guillaume JC,Payne CR,Wechsler J .1987 .Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol, 123 : 1160-5.
Guégan S,Bastuji‑Garin S,Poszepczynska‑Guigné E,Roujeau JC,Revuz J .2006 .Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol, 126 : 272-6.
Tennis P,Stern RS .1997 .Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. Neurology, 49 : 542-6.
0

Citations

0

Downloads

14

Views